Tandem Diabetes Care (TNDM) Operating Income Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Operating Income Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | -17.50% |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 30.74% |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 22.08% |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 49.06% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 43.83% |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 24.81% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | -95.55% |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 49.72% |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 16.18% |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn | 73.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.38% |
| Mar 31, 2026 | 85.58% |
| Dec 31, 2025 | 1,527.54% |
| Sep 30, 2025 | 12.38% |
| Jun 30, 2025 | -68.36% |
| Mar 31, 2025 | -190.03% |
| Dec 31, 2024 | 98.34% |
| Sep 30, 2024 | 17.28% |
| Jun 30, 2024 | 20.70% |
| Mar 31, 2024 | 67.39% |
| Dec 31, 2023 | -97.22% |
| Sep 30, 2023 | 33.58% |
| Jun 30, 2023 | -217.08% |
| Mar 31, 2023 | -733.34% |
| Dec 31, 2022 | -239.56% |
| Sep 30, 2022 | -715.19% |
| Jun 30, 2022 | -325.31% |
| Mar 31, 2022 | -373.83% |
| Dec 31, 2021 | -31.74% |
| Sep 30, 2021 | 865.11% |